All 2008 Releases
Ligand Completes Pharmacopeia Acquisition
Dec 23, 2008
|
Ligand Enters into Exclusive License Agreement with GlaxoSmithKline to License Rights to LGD-4665 and other Ligand Thrombopoietin (TPO) Molecules
Dec 18, 2008
|
Ligand Presents Positive LGD-4665 Clinical Trial Results at the American Society of Hematology Annual Meeting
Dec 8, 2008
|
Ligand Collaborator GlaxoSmithKline Receives FDA Approval for PROMACTA®
Nov 20, 2008
|
Ligand Pharmaceuticals Announces Third Quarter Results
Nov 6, 2008
|
Ligand and Pharmacopeia to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
Nov 4, 2008
|
Ligand to Hold Third Quarter Results Conference Call on November 6
Oct 28, 2008
|
Ligand and Pharmacopeia to Present At the Oppenheimer 19th Annual Healthcare Conference
Oct 28, 2008
|
Ligand to Acquire Pharmacopeia for Stock and Contingent Value Rights
Sep 24, 2008
|
Ligand Pharmaceuticals and the SALK Institute Enter Settlement Agreement and Mutual Release of All Claims
Sep 5, 2008
|
Ligand Pharmaceuticals Appoints Dr. Stephen Sabba to Board of Directors
Aug 4, 2008
|
Ligand Pharmaceuticals Announces Second Quarter Results
Jul 31, 2008
|
Ligand to Hold Second Quarter Results Conference Call on July 31
Jul 21, 2008
|
Ligand Partner GlaxoSmithKline Receives FDA Extended Priority Review for PROMACTA(R) NDA
Jun 20, 2008
|
Ligand to Present at the Needham & Company Biotechnology and Medical Technology Conference on June 11
Jun 4, 2008
|
Ligand Pharmaceuticals Announces First Quarter Results
May 1, 2008
|
Ligand Initiates Phase II Trial with LGD-4665 in Idiopathic Thrombocytopenic Purpura
Apr 24, 2008
|
Ligand to Hold First Quarter Results Conference Call on May 1
Apr 21, 2008
|
Ligand Partner GlaxoSmithKline Receives FDA Acceptance and Granted Priority Review for PROMACTA(R) NDA
Mar 3, 2008
|
Ligand Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
Feb 20, 2008
|
|
|
